Virentum turns breakthrough technology into scalable business

When the technology works, the next challenge begins

Virentum helps impact startups bridge the gap between proven technology and scalable commercial success by sharpening their value proposition and building a focused growth strategy

VIRENTUM helps impact startups turn breakthrough technology into scalable business

Many impact startups are built around breakthrough technology with the potential to create real, lasting change. In the early stages, growth is driven by research and technical progress, often long before a clear product or market exists.

But once the technology works, everything changes. Investors expect a compelling story and a scalable business case. Teams grow and need focus. And customers start asking:
What value does this create? For whom? And why now?

This is where many startups get stuck — not because the technology fails, but because the business case isn’t clear yet.

Virentum helps bridge that gap, turning innovation into a focused, scalable, and investable business.

plant biotech

Virentum works with Technically driven impact startups across industries where technology and impact are at the core: biotech, food & agritech, clean energy, circular economy, life sciences, and deeptech

Virentum works with technically driven impact startups across industries, including biotech, food & agritech, clean energy, circular economy, life sciences, and deeptech, where technology and impact are at the core, and who are ready to turn innovation into business.

While these sectors differ, the challenges are strikingly similar. These companies are R&D-heavy, operate on long timelines, and require significant upfront investment.

They also navigate complex challenges around IP, regulation, talent, and market understanding that most startups do not.

As a result, they share a common challenge: translating complex technology into a clear, compelling, and investable business case.

Virentum exists to bridge that gap.

tubes

Virentum supports startups in different phases of their lifecycle, from early-stage startups defining direction to scaleups focusing execution

early-stage startups: building direction

You have a breakthrough technology. Now you need to build a business around it.

You are wondering: Where do we focus? Who is this really for? What is the right model?

Virentum helps you define a clear commercial direction. Translating your technology into a sharp value proposition, a focused strategy, and the first steps toward product–market fit

preparing to raise: become investable

Your technology works. You have a prototype and initial team. Now you need to raise.

But investors need more than potential — they need a clear, credible business case.

Virentum helps you turn your story into an investable proposition with a strong narrative, a robust commercial strategy, and the right materials and process.

post-fundraise: focused scaling execution

You have raised capital and made bold promises to investors. Now you need to deliver.

Priorities are unclear, the organization is evolving, and expectations are rising fast.

Virentum helps you translate strategy into execution. Aligning your team, defining clear priorities and key capabilities, and building the organization to scale.

Virentum is there for the whole ecosystem, both startups and impact investors

Impact investors back startups with strong technology and high impact potential, but even when potential is clear, evaluation and execution is rarely straightforward

Virentum helps with DD as well as hands-on support for portfolio companies:

Due Dilligence: assess the commercial viability of technically complex startups. Translating technology into clear business logic, identifying key risks, and evaluating scalability and market potential

Portfolio support: work alongside portfolio companies to strengthen their commercial strategy, sharpen positioning, and accelerate their path to scalable growth

The result: better investment decisions and stronger-performing portfolio companies

zeewier

Virentum offers customized support adjusted to your needs – topics include value definition, fundraise support, coaching, and CCO as a service

value definition

Translate your technology into a clear value proposition and scalable growth strategy, covering business model, go-to-market, pricing, and roadmap

fundraise support

Turn your strategy into a compelling investor story and support your fundraising. From positioning and materials to investor targeting and process guidance

coaching & advisory

Ongoing coaching and advisory to help you and your team make the right decisions, stay focused, and navigate the complexity of scaling

CCO AS A SERVICE

Senior commercial leadership, hands-on and flexible. Helping you accelerate traction, build capabilities, and drive growth at the right pace

Caroline Wilschut

Caroline is a commercial leader with 15+ years of experience in value creation and growth strategy.

She started her career at Boston Consulting Group, where she spent a decade working on growth, market entry, and strategy for global companies.

She then joined Meatable, a pioneering foodtech startup, as Chief Commercial Officer/ VP Commerce. There, she built and led the commercial organization and played a key role in scaling the company, and in raising its total of $95M.

Today, she works with impact-driven startups to help them translate breakthrough innovation into focused, scalable, and investable businesses.

She is strongly driven by the belief that breakthrough innovation deserves breakthrough growth




photo caroline wilschut

Let’s talk

Building something with real impact and ready to turn it into a scalable business?

Let’s explore how we can work together

Virentum – Caroline Wilschut – Turning breakthrough technology into scalable business

Virentum